Protara Therapeutics, Inc. Realized Investment Gains (Losses)
Protara Therapeutics, Inc. (TARA) reported Realized Investment Gains (Losses) of $9.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RealizedInvestmentGainsLosses · last filed 2026-03-10
- Protara Therapeutics, Inc. realized investment gains (losses) for the quarter ending 2024-03-31 was $0.00.
- Protara Therapeutics, Inc. realized investment gains (losses) for fiscal 2025 was $9.00K.
- Protara Therapeutics, Inc. realized investment gains (losses) for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Protara Therapeutics, Inc. realized investment gains (losses) for fiscal 2022 was $17.00K.
| Period end | Realized Investment Gains (Losses) | Realized Investment Gains (Losses) 3 month | Realized Investment Gains (Losses) 12 month |
|---|---|---|---|
| 2025-12-31 | $9.00K 10-K · filed 2026-03-10 | ||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-02 | ||
| 2023-12-31 | $0.00 10-K · filed 2024-03-13 | ||
| 2023-01-01 | $0.00 10-Q · filed 2024-05-02 | ||
| 2022-12-31 | $17.00K 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |